The first study reported a 93% (15 of 16 patients) treatment response, evidenced by no residual tumour on histology, although six subjects withdrew prematurely because of local skin reactions and were not included in the final analysis.88 An ITT analysis showed that 87-5% (14 of 16 patients) had no residual tumour. All immunocompromised patients showed complete clinical response within 4 weeks of therapy and histological response at 20 weeks after initiation of therapy.89
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.